ASTRIA THERAPEUTICS
Catabasis Pharmaceuticals is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. Their platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of a novel mechanism of action therapies to safely and effectively treat inflammatory diseases.
ASTRIA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.astriatx.com
Total Employee:
11+
Status:
Active
Contact:
(617) 349-1971
Email Addresses:
[email protected]
Total Funding:
656.44 M USD
Technology used in webpage:
SPF IPv6 Microsoft Exchange Online Google Office 365 Mail Microsoft Azure DNS COVID-19 Akamai Hosted Mimecast InMotion Hosting
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
BTNX
BTNX is a biotech firm that specializes in R&D and the manufacture of advanced in-vitro diagnostic tests and point-of-care diagnostics.
Ceria Therapeutics
Ceria Therapeutics develops innovative and novel therapies to treat overactive and nonproductive inflammation to promote healing.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-29 | Quellis Biosciences | Quellis Biosciences acquired by Astria Therapeutics | N/A |
Investors List
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Astria Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Astria Therapeutics
TCG Crossover
TCG Crossover investment in Post-IPO Equity - Astria Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - Astria Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Astria Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Astria Therapeutics
SV Health Investors
SV Health Investors investment in Series B - Astria Therapeutics
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Astria Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series B - Astria Therapeutics
MedImmune Ventures
MedImmune Ventures investment in Series B - Astria Therapeutics
Key Employee Changes
Official Site Inspections
http://www.astriatx.com Semrush global rank: 14.09 M Semrush visits lastest month: 60
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Astria Therapeutics"
About Us - Astria Therapeutics
With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by allergic and …See details»
Home - Astria Therapeutics
With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by allergic and …See details»
Investor Overview | Astria Therapeutics
Jun 6, 2025 Overview With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families …See details»
Astria Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Our second program, STAR-0310, is an investigational monoclonal antibody OX40 antagonist in clinical development for the treatment of atopic dermatitis. Learn more about our …See details»
Astria Therapeutics - Crunchbase Company Profile
Astria Therapeutics discovers and develops innovative drugs for treating inflammatory conditions.See details»
Overview, News & Similar companies - ZoomInfo.com
Nov 13, 2023 View Astria Therapeutics (www.astriatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Astria Therapeutics to Present at Upcoming American Academy of …
Feb 20, 2025 BOSTON -- (BUSINESS WIRE)--Feb. 20, 2025-- Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies …See details»
Astria Therapeutics to Present at Upcoming American Academy
Feb 20, 2025 BOSTON-- (BUSINESS WIRE)-- Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and …See details»
Our Commitment to Inclusion & Belonging - Astria Therapeutics
We invest in our people through our words, our actions, and our values. We are working to develop and implement initiatives that promote inclusion and belonging throughout the …See details»
Astria Therapeutics Announces Exclusive Worldwide License …
Oct 11, 2023 BOSTON -- (BUSINESS WIRE)--Oct. 11, 2023-- Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing …See details»
Astria's Navenibart HAE Treatment: Phase 3 Design and Clinical …
Feb 20, 2025 New Phase 3 trial design and attack severity reduction data for navenibart in HAE treatment to be presented, alongside novel OX40 antibody developments.See details»
Our Science - Astria Therapeutics
With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by allergic and …See details»
Corporate Responsibility | Astria Therapeutics - ir.astriatx.com
We’re proud to share our Corporate Responsibility Report, which highlights how we’re working to make a difference for patients and families, healthcare providers, our team members, our …See details»
Astria Therapeutics Announces Positive Initial Results from the …
Jun 13, 2025 The poster is accessible to conference attendees and also in the Scientific Presentations and Publications section of www.astriatx.com. In February 2025, Astria initiated …See details»
astriatx.com Reviews: Is this site a scam or legit?
Is astriatx.com legit or a scam? Read reviews, company details, technical analysis, and more to help you decide if this site is trustworthy or fraudulent.See details»
Corporate Responsibility - Astria Therapeutics
We’re proud to share our Corporate Responsibility Report, which highlights how we’re working to make a difference for patients and families, healthcare providers, our team members, our …See details»
Astria Therapeutics Reports First Quarter 2025 Financial Results …
Mar 31, 2025 Our second program, STAR-0310, is an investigational monoclonal antibody OX40 antagonist in clinical development for the treatment of atopic dermatitis. Learn more about our …See details»
Resources - Astria Therapeutics
With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by allergic and …See details»
AD Patient Resources - Astria Therapeutics
With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by allergic and …See details»
Astria Therapeutics Announces Design of ALPHA-ORBIT Pivotal …
Jan 13, 2025 BOSTON -- (BUSINESS WIRE)--Jan. 13, 2025-- Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing …See details»